Chief executive Denis Corin will give a presentation on Monday (March 12), while he will also be available for one-on-one investor meetings on Monday and Tuesday (March 13).
View full QBIO profile View Profile
The heparin test is the firm’s lead product; however the company’s OxiChek device for oxidative stress is also gaining traction
The proceeds from the fundraiser will be used to expand in the People's Republic and will invested in product development
The company has developed a "unique and superior pressure" cycling technology (PCT), says Zacks.